SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Dagna O. Constenla · Study

Home/Author

Dagna O. Constenla

9 works· latest 2022· 2 institutionscluster: provisionalORCID 0000-0003-4935-1584

h-index9

i109

Citations450

Works here9

14

16

18

20

22

Most cited in this library

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–302020 · 142 citations
The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries2018 · 84 citations
Reassessing the value of vaccines2014 · 63 citations
Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches2020 · 46 citations
Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study2018 · 44 citations

Works

9 shown

Unveiling the contributions of immunization for progressing towards Universal Health Coverage

Human Vaccines & Immunotherapeutics·2022·7 authors·editorial·Open access

12citations

The economic burden of measles in children under five in Bangladesh

BMC Health Services Research·2020·9 authors·Open access

16citations

Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030

Value in Health·2020·6 authors·Open access

30citations

Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches

Value in Health·2020·6 authors·Open access

46citations

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

Health Affairs·2020·5 authors·Open access

142citations

Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study

BMJ Global Health·2018·7 authors·Open access

44citations

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

Health Affairs·2018·15 authors·Open access

84citations

The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique

Vaccine·2016·9 authors·Open access

13citations

Reassessing the value of vaccines

The Lancet Global Health·2014·29 authors·Open access

63citations